ASH 2016 Updates: Practice-Changing Abstracts

Chicago, IL US
March 4, 2017
Our goal is to join community-based providers and academic oncologists to reach our Healthy People 2020 target of 160.0 cancer related deaths per 100,000 individuals or lower. In order to reach this goal, the Annual ASH 2016 Updates: Practice Changing Abstracts addresses early treatment options and medical advances that can be implemented in an effort to reduce cancer related deaths. It will provide physicians and other health professionals with information that will improve their competence and ultimately improve patient outcomes by bridging the gap between the level of care provided in the community and the care provided at an academic medical center. By providing them with important developments for the most recent ASH conference, we want to educate and empower community-based oncologists on best practices for treating hematologic cancers and also inform them of the indicators of when a patient needs to be referred for tertiary level care.
 

Target Audience

This activity has been designed for physicians and other healthcare professionals interested in the treatment of hematologic cancers.

Learning Objectives

At the conclusion of this activity, participants will be able to:

  • Describe the bone marrow findings and cytogenetics seen in patients with myelodysplastic/myeloproliferative neoplasms;
  • Identify the predominant cell types seen in the peripheral blood and bone marrow in acute myeloid leukemia;
  • Name common symptoms  and laboratory findings in a patient presenting with acute lymphoblastic leukemia;
  • Name the major criteria used to diagnose multiple myeloma;
  • Describe the short- and long-term complications of radiation therapy;
  • Relate the risks of second malignancies of Hodgkin lymphoma;
  • Differentiate between the clinical features of follicular lymphoma and diffuse large B-cell lymphoma.

 

Additional information
ABMS Core Competencies: 
Patient Care and Procedural Skills
Medical Knowledge
For more information, please contact:
CME Coordinator Contact Name: 
Aaron Chrisman
CME Coordinator Contact Email: 
CME Coordinator Contact Phone: 
773-702-1123
Summary
Available credit: 
  • 4.50 AMA PRA Category 1 Credit™
  • 4.50 Participation
Event starts: 
03/04/2017 - 9:00am
Event ends: 
03/04/2017 - 1:00pm
Activity opens: 
03/04/2017
Activity expires: 
09/04/2017
Gleacher Center
450 N Cityfront Plaza
Chicago, IL 60611
United States
COURSE DIRECTOR
  Michael Bishop, MD
  Professor of Medicine
  Director, Hematopoietic Stem Cell Transplantation Program
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
Credit Designation Statement
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 4.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 
 
Nurses and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board. 

 

To register, click the button below:

REGISTER NOW!

 

Please login or create an account to proceed.